Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus

Author： Velásquez-Mieyer Pedro A Neira Claudia P

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.13, 2008-09, pp. : 2377-2382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biphasic insulin aspart in the treatment of type 2 diabetes mellitus

By Cucinotta Domenico Russo Giuseppina T

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2905-2911

Informa Healthcare

Access to resources Recommend Favorite

Insulin aspart plus insulin protamine aspart [biphasic insulin aspart 30] may improve glycaemic control in patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Biphasic Insulin Aspart in Type 2 Diabetes Mellitus: An Evidence-Based Medicine Review

By Gough S.C.L.

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 299-324

Adis International

Access to resources Recommend Favorite

Postprandial insulin aspart is `an attractive and feasible therapeutic option' in type 1 diabetes mellitus

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Insulin Aspart: A Review of its Use in the Management of Type 1 or 2 Diabetes Mellitus

By Reynolds Neil A. Wagstaff Antona J.

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1957-1974

Adis International

Access to resources Recommend Favorite